MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Cathcart who wrote (697)	2/18/1998 9:40:00 PM
From: the eagle	Read Replies (1) of 1826

david, i think that you posted some info attributable to blitzer regarding the outlook for a european partner for distribution. it sounded like info blitzer gave at an annual stockholders meeting. i wish you could give us the benefit of those comments again so we might read between the lines. it seems that mogn wants to keep the north american market all to mogn and let the other deals pay for the trials. again, mogn has great mgt, great balance sheet, on the road to profitabilty, a potential blockbuster drug, and the potential to have someone else to bear the cost of bringing the drug to market. seems to me mogn has very little downside risk and a tremendous upside for those that are patient.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next